T2 Biosystems (TTOO) Research Revenue Drives a 66% PT Increase At Leerink

September 12, 2019 8:01 AM EDT Send to a Friend
T2 Biosystems (NASDAQ: TTOO)
SVB Leerink analyst, Puneet Souda, reiterated his Outperform rating on shares of T2 Biosystems, Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login